CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Transparency: Turning Business Constraint into Commercial Advantage
Drug Discovery, Development & Delivery V7 I1

Transparency: Turning Business Constraint into Commercial Advantage

The pharmaceutical industry, one of the most crucial in the world in terms of impact on the lives of patients – from relieving pain to conquering disease – is in the...
Continue Reading →
Producing Colorectal Cancer Vaccine:  Combining Forces between Denmark and Estonia
Drug Discovery, Development & Delivery V7 I1

Producing Colorectal Cancer Vaccine: Combining Forces between Denmark and Estonia

Dr Eric Leire, M.D., MBA, Chief Executive Officer, president and director of the board of DanDrit Biotech USA, Inc, and Kairit Tints, Head of Quality and Qualified P...
Continue Reading →
The Growing Prominence and Need of Patient Reported Outcomes
Editorial Archive

The Growing Prominence and Need of Patient Reported Outcomes

The challenge for pharmaceutical commercialisation no longer ends with regulatory approval; it intensifies after the approval. Today there is greater awareness about...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026